End-to-end microfluidic manufacturing of personalized cancer treatments
Time: 2:00 pm
day: Day Two
Details:
- Single-use biochips eliminate patient-to-patient risk of cross-contamination
- Personalized manufacturing and release process with NMU-Symphony™
- From RNA-design to patient-injectable vials in 3 weeks
